About ZENSUN ENT Company

Zheng Shang Industrial Co., Ltd. (the “Company”) was established in 1965 and has been listed on the main board of the Hong Kong Stock Exchange Limited (the “Stock Exchange”) since 1972. The Company was included in the MSCI Hong Kong Small Cap Index in May 2021 and included in the Hang Seng Composite Index in March 2022, respectively. The Company and its subsidiaries (collectively, the “Group”) are mainly engaged in property development, property investment, project management and sales services, hotel operations, and securities trading and investment in Hong Kong, the People's Republic of China (“China”) and overseas. Following the change in the controlling shareholder of the Company in July 2015, the Group continued to expand its business in the Chinese property development industry. From mid-2015 to 2022, the Group completed 161 land reserves in Henan, Beijing and Hubei provinces to support real estate development business through tenders, public auctions and other mergers and acquisitions. As of December 31, 2022, the Group owned 41 completed property projects and/or project phases and 55 integrated property projects currently under development and planning in China (a total of 116 plots). The project in question constitutes the Group's land reserve, covering a total area of about 4.62 million square meters and an estimated total construction area (“construction area”) of about 9.87 million square meters. The land reserve provides the Group with an estimated sale/leasable floor area of about 6.21 million square meters under development and an estimated planned construction area of about 3.66 million square meters. After actively completing land acquisitions in recent years, the Group will build a solid land reserve for the Chinese property development business in the next three to four years and occupy a seat in Henan Province. In the foreseeable future, the company will continue to focus on finding new property development projects in Henan Province and other first-tier and second-tier cities in China and bidding for land use rights for other selected plots in China. In 2022, the Group began operating a new hotel in Zhengzhou, the first LOFT themed space art hotel in Zhengzhou, China - Zhengshang Jianguo Hotel. In January 2023, Zhengshang Jianguo Hotel was awarded the “2022 Best Reputation Hotel” by Ctrip. In the US, the Japanese Group held approximately 5.7% of the shares in Global Medical REIT, Inc. (“GMR”), a real estate investment trust fund listed on the New York Stock Exchange on December 31, 2022, and continued to share GMR's growth through the receipt of dividend income, thereby achieving long-term capital appreciation of the Group's investments. The Company will make good use of the Group's financial, human and technical resources to enhance its investment portfolio, asset base and brand image in China, the US and overseas to create new sustainable revenue streams, thereby increasing shareholder value.